NYSEARCA:INFU - NYSE Arca - US45685K1025 - Common Stock - Currency: USD
Overall INFU gets a fundamental rating of 6 out of 10. We evaluated INFU against 102 industry peers in the Health Care Providers & Services industry. INFU scores excellent on profitability, but there are some minor concerns on its financial health. INFU is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make INFU suitable for growth investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.06% | ||
ROE | 5.78% | ||
ROIC | 7.47% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 6.07% | ||
PM (TTM) | 2.32% | ||
GM | 53.13% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.52 | ||
Debt/FCF | 12.54 | ||
Altman-Z | 2.56 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.21 | ||
Quick Ratio | 1.83 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 44.36 | ||
Fwd PE | 18.19 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 56.92 | ||
EV/EBITDA | 7.29 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
6.21
+0.11 (+1.8%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 44.36 | ||
Fwd PE | 18.19 | ||
P/S | 0.95 | ||
P/FCF | 56.92 | ||
P/OCF | 5.96 | ||
P/B | 2.36 | ||
P/tB | 2.88 | ||
EV/EBITDA | 7.29 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.06% | ||
ROE | 5.78% | ||
ROCE | 9.46% | ||
ROIC | 7.47% | ||
ROICexc | 7.6% | ||
ROICexgc | 8.58% | ||
OM | 6.07% | ||
PM (TTM) | 2.32% | ||
GM | 53.13% | ||
FCFM | 1.66% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.52 | ||
Debt/FCF | 12.54 | ||
Debt/EBITDA | 1.35 | ||
Cap/Depr | 151.51% | ||
Cap/Sales | 14.23% | ||
Interest Coverage | 250 | ||
Cash Conversion | 102.77% | ||
Profit Quality | 71.76% | ||
Current Ratio | 2.21 | ||
Quick Ratio | 1.83 | ||
Altman-Z | 2.56 |